Social Media Ideas for Cnscx

Invesco Convertible Securities Fund Q1 2026 Commentary

Insilico’s Chinese partner returns for $177M pact to explore ‘mass market’ CNS indication

Pharma platform company China Medical System Holdings has tapped up existing partner Insilico for a 1.2 billion yuan ($177 million) collaboration aimed at a “mass-market” central n...

Conexeu Sciences: Hanging On The FDA 510(k) Pathway Submission

Columbia Small Cap Growth Fund Q1 2026 Commentary

Pyxis Oncology: The Market Might Have Already Ruled On Micvotabart Pelidotin

NIE: High Tech Exposure Poses Risks For This High Yielding CEF

<![CDATA[FDA Sends CRL to Cingulate for CTx-1301]]>

What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing

Xenon Pharmaceuticals develops therapies for neurological disorders, with a pipeline targeting epilepsy and related conditions.

What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing

Xenon Pharmaceuticals develops therapies for neurological disorders, with a pipeline targeting epilepsy and related conditions.

Neurocrine Biosciences, Inc. (NBIX) Presents at 46th Annual William Blair Growth Stock Conference Transcript

Telix Pharmaceuticals Limited (TLX) Discusses Neurologic Oncology Portfolio and Advances in Therapeutic and Diagnostic A...

CXApp Inc. (NASDAQ:CXAI) Invites Shareholders to attend 2026 Annual Meeting of Shareholders

Meeting to be held Tuesday, June 16, at 2 p.m. Pacific Time

NRx Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call Transcript

XL20 Crosses Blood-Brain Barrier to Shield ALS Neurons

A new study introduces XL20, an experimental small-molecule drug that crosses the blood-brain barrier to selectively block a toxic region on the TDP-43 protein. This precise mechan...

Nebius: Meta Anxiety Gift

Olenox Industries Completes Acquisition of PsyLinks Neurotech Corp. to Expand its Applied Intelligence Capabilities

Acquisition adds applied artificial intelligence and data analytics capabilities to support Olenox's technology and digital infrastructure strategy 

Cytosorbents Corporation (CTSO) Presents at Life Sciences Virtual Investor Forum - Slideshow

Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline

Bright Minds Biosciences develops serotonin-based therapeutics for neurological and neuropsychiatric conditions in a pre-clinical model.

Biggest stock movers Tuesday: CRNX, RIVN, and more

<![CDATA[Pharmaceutical Executive Daily: FDA Sends Complete Response Letter for Cingulate's CTx-1301]]>

NRx Pharmaceuticals: 'Sell' On ZYESAMI/NRX-101 Failures & Depression Market Uncertainty

Axon: Time To Pull The Trigger (Rating Upgrade)

CXApp (CXAI) Q1 2026 Earnings Call Transcript

Image source: The Motley Fool. DATEWednesday, May 13, 2026 at 5:30 p.m. ETCALL PARTICIPANTSChief Executive Officer — Khurram SheikhChief Financial Officer — Joy MbanugoNeed a quot...

CXApp (CXAI) Q1 2026 Earnings Call Transcript

Image source: The Motley Fool. DATEWednesday, May 13, 2026 at 5:30 p.m. ETCALL PARTICIPANTSChief Executive Officer — Khurram SheikhChief Financial Officer — Joy MbanugoNeed a quot...